跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
beta-L-fucose
首页
药物
beta-L-fucose
Experimental
Small Molecule
beta-L-fucose
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
技术标识符
化学式
C
6
H
12
O
5
CAS 编号
13224-93-6
UNII ID
3MLV1G4S4M
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
frozen powder preparation for injection of L-gossypol or acetate of L-gossypol for treatment of tumor
CN 102144979 B
申请人: SHANDONG HONGLI LAB ANIMAL EXPERIMENT RES CO LTD
优先权: 2011
CN
Capsule for subsequent filainous uveitis after cataract surgery
CN 106038603 A
申请人: ZHONG ZHIMIN
优先权: 2016
CN
Mussel polysaccharide as well as preparation method and application thereof
CN 109879981 A
申请人: UNIV ZUNYI MEDICAL
优先权: 2019
CN
Novel application of L-fucose
CN 112545912 A
申请人: INFINITUS CHINA CO LTD
优先权: 2019
CN
Etoposide glycoside, preparation method thereof and application of etoposide glycoside as anti-cancer drug
CN 115279915 A
申请人: DIREBIO MEDICAL CO LTD
优先权: 2020
CN
2apos is produced; construction method and application of recombinant escherichia coli of fucosyllactose
CN 116676243 A
申请人: UNIV CHINA AGRICULTURAL
优先权: 2022
CN
Boletus aereus polysaccharide as well as extraction method and application thereof
CN 116284469 A
申请人: NANJING UNIVERSITY OF TECHNOLOGY
优先权: 2023
CN
Construction method and application of recombinant escherichia coli with high yield of lactoyl-N-fucosyl pentasaccharide I
CN 116536232 A
申请人: UNIV JIANGNAN
优先权: 2023
CN
Recombinant escherichia coli, construction method thereof and method for producing 2 '-fucosyllactose
CN 116555145 A
申请人: COFCO NUTRITION & HEALTH RES INST CO LTD
优先权: 2023
CN
Construction and application of recombinant escherichia coli for efficiently synthesizing difucosyllactose from beginning
CN 117925492 A
申请人: UNIV CHINA AGRICULTURAL
优先权: 2024
CN
第 1 / 2 页
上一页
下一页
药物
反馈